Alzheimer’s Disease Caused by Human Growth Hormone Treatment: New Research
One of the main causes of Alzheimer’s disease is the accumulation of a pathogenic form of beta-amyloid protein in the brain. Typically, the disease occurs sporadically due to the accumulation of mutations towards the end of adult life or, less commonly, due to an inherited defective gene. In a new article published in the magazine … Read more
The post Alzheimer’s Disease Caused by Human Growth Hormone Treatment: New Research appeared first on World Today News.
Alzheimer’s Disease Caused by Human Growth Hormone Treatment: New Research
Health red alert, drugs removed from the market. Some are “lifesavers”
2024-01-29 10:11:00 Healthcare, pharmacies are missing 3,494 medicines. Some are no longer produced at all The…
The post Health red alert, drugs removed from the market. Some are “lifesavers” appeared first on TIme News.
https://time.news/health-red-alert-drugs-removed-from-the-market-some-are-lifesavers/
When the RSA is needed for the elderly and not only: how to access it, how much to pay, when nothing is due
We are among the longest-lived countries in the world; As we age, however, we often live with…
The post When the RSA is needed for the elderly and not only: how to access it, how much to pay, when nothing is due appeared first on Breaking Latest News.
https://www.breakinglatest.news/health/when-the-rsa-is-needed-for-the-elderly-and-not-only-how-to-access-it-how-much-to-pay-when-nothing-is-due-2/
EASE Trial: Anticoagulant Agatroban May Improve Prognosis for Acute Ischemic Stroke Patients With Early Neurological Deterioration
▲Image source: Getty Image Bank. [메디칼업저버 박선혜 기자] The possibility that parenteral anticoagulants may be effective in improving the prognosis of acute ischemic stroke patients presenting with early neurological deterioration (END) has been suggested. Results from the randomized EASE trial conducted in China showed that intravenous administration of the anticoagulant agatroban along with standard antiplatelet […]
The post EASE Trial: Anticoagulant Agatroban May Improve Prognosis for Acute Ischemic Stroke Patients With Early Neurological Deterioration appeared first on News Directory 3.
